vs
通用电气医疗（GEHC）与Check-Cap Ltd（MBAI）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Check-Cap Ltd的118856.9倍（$5.7B vs $47.9K）。通用电气医疗净利率更高（10.3% vs 2.3%，领先8.0%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
Check-Cap Ltd是一家处于临床阶段的医疗科技企业，专注于研发非侵入性结直肠癌筛查方案，核心产品为无需提前清肠的可吞服成像胶囊，面向全球医疗市场，致力于提升高危人群早期结直肠癌筛查的可及性。
GEHC vs MBAI — 直观对比
营收规模更大
GEHC
是对方的118856.9倍
$47.9K
净利率更高
GEHC
高出8.0%
2.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $47.9K |
| 净利润 | $588.0M | $1.1K |
| 毛利率 | 39.7% | 5.2% |
| 营业利润率 | 14.5% | 2.9% |
| 净利率 | 10.3% | 2.3% |
| 营收同比 | 7.1% | — |
| 净利润同比 | -18.4% | 100.0% |
| 每股收益（稀释后） | $1.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCMBAI
| Q4 25 | $5.7B | $47.9K | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $4.8B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $4.8B | — | ||
| Q1 24 | $4.7B | — |
净利润GEHCMBAI
| Q4 25 | $588.0M | $1.1K | ||
| Q3 25 | $446.0M | — | ||
| Q2 25 | $486.0M | — | ||
| Q1 25 | $564.0M | — | ||
| Q4 24 | $721.0M | — | ||
| Q3 24 | $470.0M | — | ||
| Q2 24 | $428.0M | — | ||
| Q1 24 | $374.0M | — |
毛利率GEHCMBAI
| Q4 25 | 39.7% | 5.2% | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — | ||
| Q1 24 | 40.9% | — |
营业利润率GEHCMBAI
| Q4 25 | 14.5% | 2.9% | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 13.2% | — | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | 12.6% | — | ||
| Q1 24 | 11.6% | — |
净利率GEHCMBAI
| Q4 25 | 10.3% | 2.3% | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 8.0% | — |
每股收益（稀释后）GEHCMBAI
| Q4 25 | $1.28 | — | ||
| Q3 25 | $0.98 | — | ||
| Q2 25 | $1.06 | — | ||
| Q1 25 | $1.23 | — | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $1.02 | — | ||
| Q2 24 | $0.93 | — | ||
| Q1 24 | $0.81 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $94.3K |
| 总债务越低越好 | $10.0B | — |
| 股东权益账面价值 | $10.4B | $1.4K |
| 总资产 | $36.9B | $184.9K |
| 负债/权益比越低杠杆越低 | 0.96× | — |
8季度趋势，按日历期对齐
现金及短期投资GEHCMBAI
| Q4 25 | $4.5B | $94.3K | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.9B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $2.6B | — |
总债务GEHCMBAI
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — | ||
| Q1 24 | $9.3B | — |
股东权益GEHCMBAI
| Q4 25 | $10.4B | $1.4K | ||
| Q3 25 | $10.0B | — | ||
| Q2 25 | $9.7B | — | ||
| Q1 25 | $9.2B | — | ||
| Q4 24 | $8.4B | — | ||
| Q3 24 | $8.3B | — | ||
| Q2 24 | $7.8B | — | ||
| Q1 24 | $7.4B | — |
总资产GEHCMBAI
| Q4 25 | $36.9B | $184.9K | ||
| Q3 25 | $36.1B | — | ||
| Q2 25 | $35.5B | — | ||
| Q1 25 | $33.6B | — | ||
| Q4 24 | $33.1B | — | ||
| Q3 24 | $33.9B | — | ||
| Q2 24 | $31.9B | — | ||
| Q1 24 | $32.2B | — |
负债/权益比GEHCMBAI
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — | ||
| Q1 24 | 1.25× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-89.2K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | -81.94× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GEHCMBAI
| Q4 25 | — | $-89.2K | ||
| Q3 25 | — | — | ||
| Q2 25 | $94.0M | — | ||
| Q1 25 | $250.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-119.0M | — | ||
| Q1 24 | $419.0M | — |
自由现金流GEHCMBAI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-183.0M | — | ||
| Q1 24 | $274.0M | — |
自由现金流率GEHCMBAI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | 5.9% | — |
资本支出强度GEHCMBAI
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 3.1% | — |
现金转化率GEHCMBAI
| Q4 25 | — | -81.94× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.44× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.28× | — | ||
| Q1 24 | 1.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
MBAI
暂无分部数据
